Who owns DexCom (DXCM)? Superinvestor holders
2 superinvestors of the 157 tracked here hold DexCom (DXCM) in their latest 13F filing, with $1.5B between them. Baillie Gifford team gives it the most weight: 1.18% of the reported portfolio. In their latest reported quarter, Jim Simons (1938–2024) added; Baillie Gifford team reduced.
Key facts
- Superinvestors holding it
- 2 of 157
- Biggest holder
- Baillie Gifford team, $1.3B
- Largest weight
- Baillie Gifford team, 1.18%of their portfolio
- Combined value
- $1.5B
- Bought last quarter
- 1
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford teamBaillie Gifford & Co | 1.18% | $1.3B | 14.52M | ▼ Reduced 1.9% | −279.75K | Q3 2026 |
| 2 | Jim Simons (1938–2024)Renaissance Technologies | 0.28% | $202.5M | 2.35M | ▲ Added 44% | +715.42K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 2 | 16.87M | $1.5B | 1 | 1 |
| Q2 2026 | 157 | 2 | 16.43M | $1.1B | 1 | 2 |
| Q1 2026 | 157 | 2 | 17.18M | $1.1B | 2 | 0 |
| Q4 2025 | 157 | 2 | 19.49M | $1.3B | 1 | 3 |
| Q3 2025 | 157 | 6 | 35.7M | $2.4B | 4 | 2 |
| Q2 2025 | 157 | 3 | 28.61M | $2.5B | 1 | 3 |
| Q1 2025 | 156 | 3 | 27.68M | $1.9B | 0 | 3 |
| Q4 2024 | 156 | 7 | 39.78M | $3.1B | 6 | 1 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Baillie Gifford team | 14.52M | 14.8M | 15.6M | 15.55M | 15.88M | 16.71M | 14.18M | 14.61M |
| Jim Simons (1938–2024) | 2.35M | 1.63M | 1.58M | — | — | — | — | — |
| David Shaw (founder) | · | — | — | 3.94M | — | 1.96M | 3.08M | 3.53M |
| Ken Griffin | · | — | — | — | 6.78M | — | — | 4.26M |
| Frank Sands | — | — | — | — | 4.93M | 9.95M | 10.41M | 11.11M |
| Israel Englander | · | — | — | — | 3.43M | — | — | 3.08M |
| Brandon Haley | · | — | — | — | 2.44M | — | — | 1.59M |
| Steve Cohen | · | — | — | — | 2.24M | — | — | 1.6M |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own DXCM?
In their latest 13F filings: Baillie Gifford team (1.18% of the portfolio, $1.3B), Jim Simons (1938–2024) (0.28% of the portfolio, $202.5M).
Who bought DXCM last quarter?
Jim Simons (1938–2024) (added 44%). “Last quarter” is each investor's latest reported quarter.
Who sold DXCM last quarter?
Reduced: Baillie Gifford team (1.9% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns DexCom (DXCM)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/DXCM/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to DXCM by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.